View of The effect of biological anti-TNF-α therapy, originator and biosimilar, used to treat ankylosing spondylitis was studied based on clinical and blood counts and an inflammatory marker

Return to Article Details The effect of biological anti-TNF-α therapy, originator and biosimilar, used to treat ankylosing spondylitis was studied based on clinical and blood counts and an inflammatory marker Download Download PDF